Demuris and collaborators identify antibiotic with potential to treat Multi-Drug-Resistant Tuberculosis

Demuris Ltd, in collaboration with UK and US scientists, have identified an antibiotic that may have potential in treating the 600,000 cases per year of Multi-Drug-Resistant Tuberculosis (MDR-TB). The World Health Organisation (WHO) estimates that someone dies from TB every 20 seconds, or around 1.7 million people per year. Mycobacterium tuberculosis is the causative agent …

Demuris and collaborators identify antibiotic with potential to treat Multi-Drug-Resistant Tuberculosis Read More »